Biomet Hip Lawsuits Move Forward, As Bernstein Liebhard LLP Notes Issuance of New Case Management Order in Federal Multidistrict Litigation
The Firm is representing a number of Biomet hip replacement clients in the federal proceeding, all of whom allege serious injuries do the metal-on-metal design of the Biomet M2a Magnum Hip Replacement System.
New York, New York (PRWEB) December 08, 2013
Nearly 800 Biomet hip lawsuits (http://www.consumerinjurylawyers.com/biomet-magnum-hip-replacement) involving the M2a Magnum Hip Replacement System continue to move forward in a multidistrict litigation underway in U.S. District Court, Northern District of Indiana, Bernstein Liebhard LLP reports. According to court documents, an Order was issued on December 3, 2013, governing the process for appointing members of the Plaintiffs’ Steering Committee for the proceeding. (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation – MDL No. 2391)
“We continue to hear from individuals who were allegedly harmed by this Biomet hip replacement on a regular basis, and our Firm is representing a number of clients in the federal litigation. We are pleased with the progress in this proceeding so far,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free and confidential Biomet hip lawsuit evaluations to individuals who may have been injured by the Biomet M2a Magnum Hip Replacement System.
Biomet Hip Lawsuits
According to court documents, the Biomet M2a Magnum hip is a metal-on-metal device in which the ball and cup consist of a chromium-cobalt alloy. Biomet hip lawsuits allege that this design is defective, and can allow dangerous amounts of metal ions to be shed in to the tissue and blood stream of recipients. The complaints further allege that recipients of this Biomet hip replacement are at risk for metallosis, pseudotumor formation, premature device failure and other serious complications that may necessitate revision of the hip.
The U.S Food & Drug Administration (FDA) issued a safety communication this past January cautioning that metal-on-metal hips were more likely to fail at five years of surgery compared to devices manufactured of other materials. Among other things, the agency has proposed regulations that would subject all-metal hips to greater regulatory scrutiny. The FDA has also advised metal-on-metal hip recipients to undergo blood testing for high levels of metal ions if they experience any symptoms that might indicate their hip implant is not functioning correctly.
Biomet M2a Magnum hip recipients may be entitled to financial compensation if they experienced any complications allegedly related to its all-metal design. For more information about Biomet hip replacements and other metal-on-metal hips, please visit Bernstein Liebhard LLP’s website. To arrange for a free case review, please call 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
For the original version on PRWeb visit: http://www.prweb.com/releases/biomet-hip-lawsuit/biomet-hip-replacement/prweb11401530.htm